Solution structure of R-elafin, a specific inhibitor of elastase

Journal of Molecular Biology

Volumn 268, Issue 3, 1997, Pages 666-677

  Francart, Céline ^a   Dauchez, Manuel ^b   Alix, Alain J P ^b   Lippens, Guy ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

Binding loop; Disulfide bridges; Elastase inhibitor; NMR; SLPI

Indexed keywords

APROTININ; ELAFIN; ELASTASE INHIBITOR; PROTEINASE INHIBITOR; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISULFIDE BOND; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY;

BOVINAE;

EID: 0031560771     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1997.0983     Document Type: Article

References (47)

1. Alix A. J. P., Goulyaev D., Efremov R. Global and local secondary structures of globular proteins: linking spectroscopies and predictions. Spectroscopy of Biological Molecules. 1995;Kluwer Academic Press.
2. Berndt K. D., Güntert P., Orbons L. P. M., Wüthrich K. Determination of a high-quality nuclear magnetic resonance solution structure of the bovine pancreatic trypsin inhibitor and comparison with three crystal structures. J. Mol. Biol. 227:1992;757-775.
3. Bieth J. G. Mechan R. D. Regulation of Matrix Accumulation. 1986;Academic Press, New York.
4. Bode W., Huber R. Natural protein proteinase inhibitors and their interaction with proteinases. Eur. J. Biochem. 204:1992;433-451.
5. Bode W., Meyer E., Jr, Powers J. C. Human leukocyte and porcine pancreatic elastase: X-ray crystal structures, mechanism, substrate specificity, and mechanism-based inhibitors. Biochemistry. 28:1989;1951-1963.
6. Brünger A. T. X-PLOR Version 3.1 Manual, 1992;Yale University, New Haven.
7. Chiche L., Gaboriaud C., Heitz A., Mornon J.-P., Castro B., Kollman P. A. Use of restrained molecular dynamics in water to determine three-dimensional protein structure: prediction of the three-dimensional structure ofEcballium elaterium. Proteins: Struct. Funct. Genet. 6:1989;405-417.
8. Clore G. M., Gronenborn A. M. Structures of larger proteins in solution: three- and four-dimensional heteronuclear nmr spectroscopy. Science. 252:1991;1390-1399.
9. 113. Biochemistry. 29:1990;8172-8184.
10. Desvaux H., Berthault P., Birlirakis N., Goldman M. Off-resonance ROESY for the study of dynamic processes. J. Magn. Reson. Ser. A. 108:1994;219-229.
11. Desvaux H., Berthault P., Birlirakis N., Goldman M., Piotto M. Improved versions of off-resonance ROESY. J. Magn. Reson. Ser. A. 113:1995;47-52.
12. Drenth J., Low B. W., Richardson J. S., Wright C. S. The toxin-agglutinin fold. A new group of small protein structure organized around a four-disulfide core. J. Biol. Chem. 255:1980;2652-2655.
13. Francart C., Wieruszeski J.-M., Tartar A., Lippens G. Structural and dynamic characterization of Procis/trans. J. Am. Chem. Soc. 118:1996;7019-7027.
14. Fritz H. Human mucous proteinase inhibitor (human MPI). Human seminal inhibitor I (HUSI-I), antileukoprotease (ALP), secretory leukocyte protease inhibitor (SLPI). Biol. Chem. Hoppe-Seyler. 369:1988;79-82.
15. Gesquiere J.-C., Diesis E., Cung M. T., Tartar A. Slow isomerization of some proline-containing peptides inducing peak splitting during reversed-phase high-performance liquid chromatography. J. Chromatog. 478:1989;121-129.
16. Grütter M. G., Fendrich G., Huber R., Bode W. The 2.5 Å X-ray crystal structure of the acid-stable proteinase inhibitor from human mucous secretions analysed in its complex with bovine α-chymotrypsin. EMBO J. 7:1988;345-351.
17. Kabsch W., Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 22:1983;2577-2637.
18. Klaus W., Broger C., Gerber P., Senn H. Determination of the disulphide bonding pattern in proteins by local and global analysis of nuclear magnetic resonance data. Application to flavoridin. J. Mol. Biol. 232:1993;897-906.
19. Kraunsoe J. A. E., Claridge T. D. W., Lowe G. Inhibition of human leukocyte and porcine pancreatic elastase by homologues of bovine pancreatic trypsin inhibitor. Biochemistry. 35:1996;9090-9096.
20. Krezel A. M., Darba P., Robertson A. D., Fejzo J., Macura S., Markley J. L. Solution structure of turkey ovomucoid third domain as determined from nuclear magnetic resonance data. J. Mol. Biol. 242:1994;203-214.
21. Laskowski R. A., MacArthur M. W., Moss D. S., Thornton J. M. PROCHECK: a program to check the stereochemical quality of protein structure. J. Appl. Crystallog. 26:1993;283-291.
22. Lippens G., Dhalluin C., Wieruszeski J. M. Use of a water flip-back pulse in the homonuclear NOESY experiment. J. Biomol. NMR. 5:1995;327-331.
23. Molhuizen H. O. F., Schalkwijk J. Structural, biochemical, and cell biological aspects of the serine proteinase inhibitor SKALP/elafin/ESI. Biol. Chem. Hoppe-Seyler. 376:1995;1-7.
24. Molhuizen H. O. F., Alkemade H. A. C., Zeeuwen P. L. J. M., de Jongh G. J., Wieringa B., Schalkwijk J. SKALP/elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking. J. Biol. Chem. 268:1993;12028-12032.
25. Otting G., Liepinsh E., Wüthrich K. Disulfide bond isomerization in BPTI and BPTI (G36S): an NMR study of correlated mobility in proteins. Biochemistry. 32:1993;3571-3582.
26. Parker F. S. Applications of Infrared, Raman and Resonance Raman Spectroscopy in Biochemistry, 1983;Plenum Press, New York.
27. Patston P. A., Gettins P. G. W. Significance of secondary structure predictions on the reactive center loop region of serpins: a model for the folding of serpins into a metastable state. FEBS Letters. 383:1996;87-92.
28. Piotto M., Saudek V., Sklenar V. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR. 2:1992;661-665.
29. Provencher S., Glöckner J. Estimation of globular secondary structure prediction from circular dichroism. Biochemistry. 20:1981;33-37.
30. Saheki T., Ito F., Hagiwara H., Saito Y., Kuroki J., Tachibana S., Hirose S. Primary structure of the human elafin precursor preproelafin deduced from the nucleotide sequence of its gene and the presence of unique repetitive sequences in the prosegment. Biochem. Biophys. Res. Commun. 185:1992;240-245.
31. Sallenave J.-M., Ryle A. P. Purification and characterization of elastase-specific inhibitor. Sequence homology with mucous proteinase inhibitor. Biol. Chem. Hoppe-Seyler. 372:1991;13-21.
32. Sallenave J.-M., Marsden M. D., Ryle A. P. Isolation of elafin and elastase-specific inhibitor (ESI) from bronchial secretions. Evidence of sequence homology and immunological cross-reactivity. Biol. Chem. Hoppe-Seyler. 373:1992;27-33.
33. Schalkwijk J., Chang A., Janssen P., de Jongh G. J., Mier P. D. Skin-derived antileukoproteinases (SKALPs): characterization of two new elastase inhibitors from psoriatic epidermis. Br. J. Dermatol. 122:1990;631-641.
34. Schechter I., Berger A. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27:1967;157-162.
35. Seemüller U., Arnhold M., Fritz H., Wiedenmann K., Machleidt W., Heinzel R., Appelhans H., Gassen H.-G., Lottspeich F. The acid-stable proteinase inhibitor of human mucous secretions (HUSI-I, antileukoprotease). Complete amino acid sequence as revealed by protein and cDNA sequencing and structural homology to whey proteins and Red Sea turtle proteinase inhibitor. FEBS Letters. 199:1986;43-48.
36. Sibanda B. L., Blundell T. L., Thornton J. M. Conformation of β-hairpins in protein structures. A systematic classification with applications to modelling by homology, electron density fitting and protein engineering. J. Mol. Biol. 206:1989;759-777.
37. Tsunemi M., Kato H., Nishiuchi Y., Kumagaye S.-I., Sakakibara S. Synthesis and structure-activity relationships of elafin, an elastase-specific inhibitor. Biochem. Biophys. Res. Commun. 185:1992;967-973.
38. Wagner G., Braun W., Havel T. F., Schaumann T., Go N., Wüthrich K. Protein structures in solution by nuclear magnetic resonance and distance geometry. The polypeptide fold of the basic Pancreatic Trypsin inhibitor determined using two different algorithms, DISGEO and DISMAN. J. Mol. Biol. 196:1987;611-639.
39. Wider G., Wüthrich K. A simple experimental scheme using pulsed field gradients for coherence-pathway rejection and solvent suppression in phase-sensitive heteronuclear correlation spectra. J. Magn. Reson. Ser. B. 102:1993;239-241.
40. Wiedow O., Schröder J.-M., Gregory H., Young J. A., Christophers E. Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J. Biol. Chem. 265:1990;14791-14795.
41. Wiedow O., Lüdemann J., Utecht B. Elafin is a potent inhibitor of proteinase 3. Biochem. Biophys. Res. Commun. 174:1991;6-10.
42. Wilmot C. M., Thornton J. M. Analysis and prediction of the different types of β-turn in proteins. J. Mol. Biol. 203:1988;221-232.
43. 1313. J. Biomol. NMR. 4:1994;171-180.
44. Wishart D. S., Sykes B. D., Richards F. M. The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry. 31:1992;1647-1651.
45. Wüthrich K. NMR of Proteins and Nucleic Acids, 1986;Wiley, New-York.
46. Ying Q.-L., Simon S. R. Kinetics of the inhibition of human leukocyte elastase by elafin, a 6-kilodalton elastase-specific inhibitor from human skin. Biochemistry. 32:1993;1866-1874.
47. Ying Q.-L., Kemme M., Simon S. R. Functions of the N-terminal domain of secretory leukoprotease inhibitor. Biochemistry. 33:1994;5445-5450.